BioLineRx Ltd. (BLRX.TA)
ILA 5.8
(-9.38%)
ILA 5.8
(-9.38%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.95 Million USD | 890.96% |
| 2022 | 197.08 Thousand USD | 55.51% |
| 2021 | 126.73 Thousand USD | -16.46% |
| 2020 | 151.7 Thousand USD | 41.41% |
| 2019 | 107.27 Thousand USD | 0.0% |
| 2018 | - USD | 100.0% |
| 2017 | -44.06 Million USD | 0.0% |
| 2016 | - USD | 100.0% |
| 2015 | -41.89 Million USD | -115585.62% |
| 2014 | -36.21 Thousand USD | -3613421057872.49% |
| 2013 | - USD | -100.0% |
| 2012 | 2.00 USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.88 Million USD | 47.93% |
| 2024 Q2 | 3.63 Million USD | 25.79% |
| 2023 FY | 1.95 Million USD | 890.96% |
| 2023 Q2 | 1.74 Million USD | 137.07% |
| 2023 Q1 | 736.96 Thousand USD | 273.94% |
| 2023 Q3 | 1.35 Million USD | -22.62% |
| 2023 Q4 | 1.95 Million USD | 44.45% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | 197.08 Thousand USD | 55.51% |
| 2022 Q4 | 197.08 Thousand USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 126.73 Thousand USD | -16.46% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 FY | 151.7 Thousand USD | 41.41% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 107.27 Thousand USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 100.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 100.0% |
| 2017 Q2 | -45.05 Million USD | -64.04% |
| 2017 Q4 | -44.06 Million USD | 8.22% |
| 2017 Q3 | -48.01 Million USD | -6.56% |
| 2017 Q1 | -27.46 Million USD | 0.0% |
| 2017 FY | -44.06 Million USD | 0.0% |
| 2016 Q2 | -37.62 Million USD | 5.85% |
| 2016 Q3 | -34.69 Million USD | 7.79% |
| 2016 Q4 | - USD | 100.0% |
| 2016 Q1 | -39.95 Million USD | 0.0% |
| 2016 FY | - USD | 100.0% |
| 2015 Q3 | -45.2 Million USD | -0.15% |
| 2015 Q4 | - USD | 100.0% |
| 2015 FY | -41.89 Million USD | -115585.62% |
| 2015 Q2 | -45.13 Million USD | 8.12% |
| 2015 Q1 | -49.12 Million USD | -2456100100.0% |
| 2014 Q2 | -24.47 Million USD | 12.42% |
| 2014 Q1 | -27.94 Million USD | -2788835792047484.4% |
| 2014 FY | -36.21 Thousand USD | -3613421057872.49% |
| 2014 Q4 | 2.00 USD | 0.0% |
| 2014 Q3 | - USD | 100.0% |
| 2013 Q1 | 2.00 USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 100.0% |
| 2013 Q2 | -8.95 Million USD | -447870737.38% |
| 2012 Q3 | 128.2 Thousand USD | 12820300.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | 265.42 Thousand USD | 0.0% |
| 2012 Q2 | 1.00 USD | -100.0% |
| 2012 Q4 | 2.00 USD | -100.0% |
| 2011 Q3 | - USD | -100.0% |
| 2011 Q4 | - USD | 100.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | 57.24 Thousand USD | 5691129928917.78% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Matricelf Ltd | - ILA | -Infinity% |